00 mg twice daily) to improve pain-free walking.
In patients with IC who cannot tolerate or have contraindications for cilostazol, we suggest a
trial of pentoxifylline (400 mg thrice daily) to improve pain-free walking.

Grade

Level of
evidence

1

A

1
1

A
B

1

B

1

A

1

B

1

C

2
2

C
A